Translate
Kalaris Therapeutics, Inc.
About
Kalaris Therapeutics, Inc. (NASDAQ:KLRS) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 17 2026
Kalaris Reports Full Year 2025 Financial Results and Provides Business Updates
Jan 28 2026
Kalaris to Present Phase 1 Clinical Data for TH103 at the Macula Society Annual Meeting
Dec 17 2025
Kalaris Therapeutics Announces Oversubscribed $50.0 Million Private Placement
Dec 17 2025
Kalaris Therapeutics Reports Positive Initial Phase 1a Data for TH103 in Treatment-Naïve Neovascular AMD
Nov 24 2025
Kalaris to Present at Noble Capital Markets 21st Annual Emerging Growth Equity Conference
Financials
Revenue
$0
Market Cap
$143.76 M
EPS
-2.85